COVID-19 Notice

Please note, our business hours have not changed. As we navigate through the Coronavirus Pandemic, our office will continue to be responsive to all inquiries during our normal business hours. If you need to reach a doctor during non-business hours, please call 201-692-9434 and follow the emergency contact instructions. You can reach us by phone at 201-692-9434 or e-mail at

Glenpoint Centre East 300 Frank W. Burr Blvd. Teaneck, New Jersey, 07666



Published Articles

In addition to medical journal publications, Dr. Hersh has written many articles in the ophthalmology press to teach other doctors about the latest techniques and research that are available.  As medical monitor for the U.S. clinical trials that led to FDA approval of crosslinking, he has actively worked both clinically and in research to help develop the best practices in treating keratoconus.  


Crosslinking: What the young ophthalmologist needs to know - EyeWorld, June, 2017

CXL advances treatment of keratoconus, ectasia - Ophthalmology Times, September 2016

Pushing the limits of corneal collagen crosslinking - EyeWorld, September 2016

Making the Most of Corneal Cross-linking - Review of Ophthalmology, September 2016

Avedro Announces Priority Review Status for Corneal Cross-linking New Drug Application!

Laser Refractive Surgery: LASIK, LASEK, PRK and PTK - Discovery Eye Foundation, September 2015

Corneal Collagen Cross-Linking and LASIK - Cataract & Refractive Surgery, July 2015

Shifting preferences in corneal transplantation - Eyeworld April 2015

Cross-linking undergoing intense study in U.S. - October 2014

Will CXL Get Approval in 2014?

Corneal collagen crosslinking still hot topic in U.S. - EyeWorld September, 2013

Keraflex® Keratoconus Treatment Study Begins in US - Hersh Vision Group is the first to offer this novel keratoconus treatment - October 11, 2012

Higher-order aberrations decrease with corneal collagen cross-linking - OSN August 2012

CXL analyses guide treatment - Ophthalmology Times June 1, 2012

Early outcomes positive for cross-linking, corneal implant treatment for keratoconus and ectasia - OSN April 25, 2012

Avedro Announces Second FDA Orphan Drug Designation for Corneal Cross-linking - January, 2012

On Thin Eyes - Review of Optometry January 15, 2012

Putting the Brakes on Corneal Ectatic Disorders - Refractive Eyecare October, 2011

Epithelium-on cross-linking growing while epithelium-off seeks FDA approval - OSN June 25, 2011

ARVO: Restoring, Protecting The Ocular Surface - Review of Optometry May 2, 2011

Wound healing after corneal cross-linking appealrs to follow consistent pattern - OSN May 10, 2011

Collagen cross-linking shows promise for slowing keratoconus ectasia - OSN, April 25, 2011

Microwave thermokeratoplasty with corneal collagen cross-linking used to treat keratoconus - March 25, 2011

Corneal haze after collagen cross-linking diminishes over time - March 25, 2011

Crosslinking a promising approach - Ophthalmology Times, March 15, 2011

Cross-linking technology for keratoconus yields positive early results - December 18, 2009

FDA backs launch of collagen cross-linking clinical trials - January 25, 2008